Sophia Watson is in urgent need of life-saving treatment for a tumor, but an insurance dispute has left her family without coverage.

Also hitting the $1bn threshold in 2018 for the first time were chronic immune thrombocytopenia drug Promacta/Revolade (eltrombopag) and melanoma duo Tafinlar (dabrafenib) and Mekinist (trametinib ...

The deal includes two recently approved GSK products for metastatic melanoma, Tafinlar and Mekinist, which will help Novartis break into this key cancer type, where BMS, Merck and Roche are all ...

In a clinical trial, patients treated with a kidney cancer vaccine remained cancer-free after a median of nearly three years.